Related Experiment Videos
Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis
Insights
Oral cephalosporins, like cefaclor, demonstrated significantly higher efficacy than penicillin in treating Group A streptococcal pharyngitis in children. Combined data from five studies confirm oral cephalosporins are a more effective treatment option.
Area of Science:
- Infectious Diseases
- Pharmacology
- Pediatrics
Background:
- Group A streptococcal pharyngitis is a common childhood infection.
- Penicillin V potassium has been the standard treatment, but concerns about efficacy and resistance exist.
- Oral cephalosporins represent an alternative therapeutic option.
Purpose of the Study:
- To compare the clinical efficacy of cefaclor versus penicillin V potassium for treating Group A streptococcal pharyngitis.
- To evaluate treatment failure rates in pediatric patients receiving either cefaclor or penicillin.
- To synthesize findings from multiple studies investigating oral cephalosporins for streptococcal pharyngitis.
Main Methods:
- A randomized controlled trial involving 104 children with confirmed Group A streptococcal pharyngitis.
- Patients were treated with either cefaclor or penicillin V potassium at a dosage of 20 mg/kg/day for 10 days.
- Meta-analysis of the current study with four previous studies comparing oral cephalosporins to penicillin.
Main Results:
- Cefaclor showed a statistically significant lower failure rate (14%) compared to penicillin V potassium (30%) in the primary study (P = 0.04).
- Combined analysis of five studies revealed a highly significant difference in failure rates, with oral cephalosporins (11%) being more effective than penicillin (23%) (P < 0.001).
- Patients receiving penicillin had 2.4 times greater odds of treatment failure compared to those on oral cephalosporins.
Conclusions:
- Oral cephalosporins, including cefaclor, demonstrate superior efficacy over penicillin for the treatment of Group A streptococcal pharyngitis.
- The findings support the use of oral cephalosporins as a preferred therapeutic agent for this common pediatric infection.
- Further research may explore long-term outcomes and resistance patterns associated with different antibiotic classes.
Abstract:
The purpose of the study was to compare the efficacy of cefaclor with that of penicillin V potassium (penicillin) in patients with Group A streptococcal pharyngitis. One hundred four children with pharyngitis and serologically confirmed Group A streptococci were randomly treated with cefaclor or penicillin using a mean dosage of 20 mg/kg/day for 10 days. The difference in failure rates (14% for 51 cefaclor- and 30% for 53 penicillin V-treated patients) was statistically significant (P = 0.04). In four earlier similar studies I found that cephaloglycin, cephalexin (two studies) and cefatrizine were consistently but not significantly more effective than penicillin therapy. When the data from the five studies are combined the difference between the failure rates (11% for 263 oral cephalosporin- and 23% for 230 penicillin-treated patients) becomes highly significant (P less than 0.001). The 95% confidence interval for the odds for treatment failure are 2.4 times greater for patients receiving penicillin than for those receiving one of the oral cephalosporins. On the basis of these data I conclude that the oral cephalosporins appear to be more effective than penicillin for therapy of Group A streptococcal pharyngitis.